Federal Clinical Recommendations. Urticaria. Updated, 2018

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


The updated Federal clinical recommendations on urticaria are presented (2018).

Restricted Access

I V Danilicheva

NRC Institute of Immunology FMBA of Russia

N I Ilina

NRC Institute of Immunology FMBA of Russia

Email: instummun@yandex.ru

L V Luss

NRC Institute of Immunology FMBA of Russia

E S Fedenko

NRC Institute of Immunology FMBA of Russia

A E Shulzhenko

NRC Institute of Immunology FMBA of Russia

  1. Аллергология. Федеральные клинические рекомендации. Главные редакторы: акад. РАН Р.М. Хаитов, проф. Н.И. Ильина. М.: «Фармарус Принт Медиа». 2014, 126 с.
  2. Maurer M., Church M.K., Goncalo M., Sussman G., Sanchez-Borges M. Management and treatment of chronic urticaria (CU) JEADV. 2015, v. 29 (Suppl. 3), p. 16-32.
  3. Paul A. Greenberger. Chronic urticaria: new management options. World Allergy Organization Journal 2014, 7:31, Sabroe and Greaves. Arch Dermatol. 1997;133:1003.
  4. Kozel M.M., Sabroe R.A. Chronic urticaria: aetiology, management and current and future treatment options, Drugs 64. 2004, p. 2515-2536.
  5. Zuberbier T, Aberer W, Asero R, et al. Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA2LEN, IAACI, IADVL, JDA, NVvA, MSAI, € OGDV, PSA, RAACI, SBD, SFD, SGAI, SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393-1414. https://doi.org/10.1111/ all.13397.
  6. Wedi B., Wieczorek D., Raap U., Kapp A. Urticaria JDDG November 2014, v. 12, p. 997-1009.


Abstract - 42

PDF (Russian) - 1




  • There are currently no refbacks.

Copyright (c) 2018 Russian Allergological Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies